

NCT02621489 comparison:

Summary:
CHIA has 21 criteria while your personal folder has 21 criteria
Total found criteria: 21/21
Total not Found: 0/21
Total Extra: 2
This trial is VALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ Patients eligible for PCI with application of DES, │ Patients eligible for PCI with application of DES, │
│ due to ACS                                         │ due to ACS                                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients with known or newly diagnosed T2D (type 2 │ Patients with known or newly diagnosed T2D (type 2 │
│ diabetes is diagnosed according to current WHO     │ diabetes is diagnosed according to current WHO     │
│ criteria or by the use of anti-diabetic drugs)     │ criteria or by the use of anti-diabetic drugs)     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Male and female subjects 18-80 years               │ Male and female subjects 18-80 years               │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ HbA1c (accordingly to IFCC) 47 mmol/mol - 110      │ HbA1c (accordingly to IFCC) 47 mmol/mol - 110      │
│ mmol/mol                                           │ mmol/mol                                           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Signed informed consent form                       │ Signed informed consent form                       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Type 1 diabetes (autoantibody positive)            │ Type 1 diabetes (autoantibody positive)            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Any history of receiving GLP-1 analogues or        │ Any history of receiving GLP-1 analogues or        │
│ dipeptidyl peptidase inhibitors within 6 months    │ dipeptidyl peptidase inhibitors within 6 months    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Known severe heart failure, classified as NYHA 4   │ Known severe heart failure, classified as NYHA 4   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Active myocarditis; malfunctioning artificial      │ Active myocarditis; malfunctioning artificial      │
│ heart valve                                        │ heart valve                                        │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ History of ventricular tachycardia within 3 months │ History of ventricular tachycardia within 3 months │
│ before study entry; second- or third-degree        │ before study entry; second- or third-degree        │
│ atrioventricular block                             │ atrioventricular block                             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Supine systolic blood pressure <85 mm Hg or >200   │ Supine systolic blood pressure \<85 mm Hg or \>200 │
│ mm Hg at screening                                 │ mm Hg at screening                                 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Primary renal impairment, creatinine clearance <   │ Primary renal impairment, creatinine clearance \<  │
│ 45 ml/min if treated with metformin                │ 45 ml/min if treated with metformin                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Uncorrected hypokalemia or hyperkalemia (potassium │ Uncorrected hypokalemia or hyperkalemia (potassium │
│ <3.5 mmol/l or >5.5 mmol/l)                        │ \<3.5 mmol/l or \>5.5 mmol/l)                      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Significant anemia (Hb < 90 g/l)                   │ Significant anemia (Hb \< 90 g/l)                  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Severe gastrointestinal disease, including         │ Severe gastrointestinal disease, including         │
│ gastroparesis. As judged by the Investigator       │ gastroparesis. As judged by the Investigator       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Body mass index (BMI) > 45 kg/m2                   │ Body mass index (BMI) \> 45 kg/m2                  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Malignant neoplasm requiring chemotherapy,         │ Malignant neoplasm requiring chemotherapy,         │
│ surgery, radiation or palliative therapy in the    │ surgery, radiation or palliative therapy in the    │
│ previous 5 years. Patients with intraepithelial    │ previous 5 years. Patients with intraepithelial    │
│ squamous cell carcinoma of the skin treated with   │ squamous cell carcinoma of the skin treated with   │
│ topical 5FU and subjects with basal cell skin      │ topical 5FU and subjects with basal cell skin      │
│ cancer are allowed to enter the trial              │ cancer are allowed to enter the trial              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Females of child bearing potential who are         │ Females of child bearing potential who are         │
│ pregnant, breast-feeding or intend to become       │ pregnant, breast-feeding or intend to become       │
│ pregnant                                           │ pregnant                                           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Current drug and alcohol abuse                     │ Current drug and alcohol abuse                     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ History of acute or chronic pancreatitis           │ History of acute or chronic pancreatitis           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Subjects considered by the Investigator to be      │ Subjects considered by the Investigator to be      │
│ unsuitable for the study                           │ unsuitable for the study                           │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



Everything was Found



╒═══════════════════════════════════╕
│ Extra Personal Criteria           │
╞═══════════════════════════════════╡
│ Must have minimum age of 18 Years │
├───────────────────────────────────┤
│ Must have maximum age of 80 Years │
╘═══════════════════════════════════╛